Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|May 24, 2008
Her-2/neu-induced "cytokine signature" in breast cancerAlejandro Vazquez-Martin, Ramon Colomer, Javier A MenendezEuropean Journal of Cancer (Oxford, England : 1990)|March 24, 2007
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancerAlejandro Vazquez-Martin, Ramon Colomer, Javier A MenendezCell Cycle (Georgetown, Tex.)|December 25, 2008
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cellsAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Javier A MenendezRejuvenation Research|November 5, 2010
Pharmacological mimicking of caloric restriction elicits epigenetic reprogramming of differentiated cells to stem-like self-renewal statesCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Javier A MenendezCell Cycle (Georgetown, Tex.)|April 18, 2009
Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cellsCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Javier A MenendezCell Cycle (Georgetown, Tex.)|June 27, 2009
The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesisAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Javier A MenendezPlos One|July 17, 2009
Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumabAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Javier A MenendezInternational Journal of Oncology|September 6, 2007
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cellsAlejandro Vazquez-Martin, Ramon Colomer, Joan Brunet, et al.Cell Cycle (Georgetown, Tex.)|April 9, 2011
Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatusAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Sílvia Cufí, et al.Cell Cycle (Georgetown, Tex.)|September 9, 2011
Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs)Alejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, et al.Pageof 8